66 related articles for article (PubMed ID: 14635044)
1. Regulation of peptide presentation by major histocompatibility complex class II molecules at the surface of macrophages.
von Delwig A; Musson JA; McKie N; Gray J; Robinson JH
Eur J Immunol; 2003 Dec; 33(12):3359-66. PubMed ID: 14635044
[TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells.
von Delwig A; Musson JA; Gray J; McKie N; Robinson JH
Immunology; 2005 Feb; 114(2):194-203. PubMed ID: 15667564
[TBL] [Abstract][Full Text] [Related]
3. Multiple class I motifs revealed by sequencing naturally processed peptides eluted from rat T cell MHC molecules.
Burrows GG; Ariail K; Celnik B; Gambee JE; Offner H; Vandenbark AA
J Neurosci Res; 1997 Jul; 49(1):107-16. PubMed ID: 9211995
[TBL] [Abstract][Full Text] [Related]
4. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model.
von Delwig A; Altmann DM; Isaacs JD; Harding CV; Holmdahl R; McKie N; Robinson JH
Arthritis Rheum; 2006 Feb; 54(2):482-91. PubMed ID: 16447222
[TBL] [Abstract][Full Text] [Related]
5. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
[TBL] [Abstract][Full Text] [Related]
6. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
[TBL] [Abstract][Full Text] [Related]
7. The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance.
Lazarski CA; Chaves FA; Jenks SA; Wu S; Richards KA; Weaver JM; Sant AJ
Immunity; 2005 Jul; 23(1):29-40. PubMed ID: 16039577
[TBL] [Abstract][Full Text] [Related]
8. No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes.
Basler M; Groettrup M
Eur J Immunol; 2007 Apr; 37(4):896-904. PubMed ID: 17357105
[TBL] [Abstract][Full Text] [Related]
9. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.
Moss CX; Villadangos JA; Watts C
Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009
[TBL] [Abstract][Full Text] [Related]
10. A role for the Hsp90 molecular chaperone family in antigen presentation to T lymphocytes via major histocompatibility complex class II molecules.
Rajagopal D; Bal V; Mayor S; George A; Rath S
Eur J Immunol; 2006 Apr; 36(4):828-41. PubMed ID: 16552710
[TBL] [Abstract][Full Text] [Related]
11. Identification of Salmonella typhimurium genes responsible for interference with peptide presentation on MHC class I molecules: Deltayej Salmonella mutants induce superior CD8+ T-cell responses.
Qimron U; Madar N; Mittrücker HW; Zilka A; Yosef I; Bloushtain N; Kaufmann SH; Rosenshine I; Apte RN; Porgador A
Cell Microbiol; 2004 Nov; 6(11):1057-70. PubMed ID: 15469434
[TBL] [Abstract][Full Text] [Related]
12. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
13. T84-intestinal epithelial exosomes bear MHC class II/peptide complexes potentiating antigen presentation by dendritic cells.
Mallegol J; Van Niel G; Lebreton C; Lepelletier Y; Candalh C; Dugave C; Heath JK; Raposo G; Cerf-Bensussan N; Heyman M
Gastroenterology; 2007 May; 132(5):1866-76. PubMed ID: 17484880
[TBL] [Abstract][Full Text] [Related]
14. Natural processing sites for human cathepsin E and cathepsin D in tetanus toxin: implications for T cell epitope generation.
Hewitt EW; Treumann A; Morrice N; Tatnell PJ; Kay J; Watts C
J Immunol; 1997 Nov; 159(10):4693-9. PubMed ID: 9366392
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
Robson NC; Donachie AM; Mowat AM
Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
[TBL] [Abstract][Full Text] [Related]
16. Bound peptide-dependent thermal stability of major histocompatibility complex class II molecule I-Ek.
Saito K; Oda M; Sarai A; Azuma T; Kozono H
Biochemistry; 2004 Aug; 43(31):10186-91. PubMed ID: 15287746
[TBL] [Abstract][Full Text] [Related]
17. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.
Hervas-Stubbs S; Majlessi L; Simsova M; Morova J; Rojas MJ; Nouzé C; Brodin P; Sebo P; Leclerc C
Infect Immun; 2006 Jun; 74(6):3396-407. PubMed ID: 16714570
[TBL] [Abstract][Full Text] [Related]
18. Localization of peptide/MHC class II complexes in macrophages following antigen processing of viable Streptococcus pyogenes.
von Delwig A; Ramachandra L; Harding CV; Robinson JH
Eur J Immunol; 2003 Sep; 33(9):2353-60. PubMed ID: 12938211
[TBL] [Abstract][Full Text] [Related]
19. Expression mapping using a retroviral vector for CD8+ T cell epitopes: definition of a Mycobacterium tuberculosis peptide presented by H2-Dd.
Aoshi T; Suzuki M; Uchijima M; Nagata T; Koide Y
J Immunol Methods; 2005 Mar; 298(1-2):21-34. PubMed ID: 15847794
[TBL] [Abstract][Full Text] [Related]
20. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
Dobaño C; Rogers WO; Gowda K; Doolan DL
Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
